SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000926617-19-000007
Filing Date
2019-03-28
Accepted
2019-03-28 17:29:05
Documents
71
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K vrml-20181231x10k.htm 10-K 1779987
2 EX-10.7 vrml-20181231xex10_7.htm EX-10.7 101104
3 EX-10.8 vrml-20181231xex10_8.htm EX-10.8 84176
4 EX-21.0 vrml-20181231xex21_0.htm EX-21.0 7512
5 EX-23.1 vrml-20181231xex23_1.htm EX-23.1 6331
6 EX-31.1 vrml-20181231xex31_1.htm EX-31.1 20575
7 EX-31.2 vrml-20181231xex31_2.htm EX-31.2 20779
8 EX-32.0 vrml-20181231xex32_0.htm EX-32.0 12401
  Complete submission text file 0000926617-19-000007.txt   7473362

Data Files

Seq Description Document Type Size
9 EX-101.INS vrml-20181231.xml EX-101.INS 1607828
10 EX-101.SCH vrml-20181231.xsd EX-101.SCH 49464
11 EX-101.CAL vrml-20181231_cal.xml EX-101.CAL 59443
12 EX-101.DEF vrml-20181231_def.xml EX-101.DEF 179240
13 EX-101.LAB vrml-20181231_lab.xml EX-101.LAB 435970
14 EX-101.PRE vrml-20181231_pre.xml EX-101.PRE 370867
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
VERMILLION, INC. (Filer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34810 | Film No.: 19713077
SIC: 2835 In Vitro & In Vivo Diagnostic Substances